Dr. Kenderian is a consultant in hematology at the Mayo Clinic Rochester, with joint appointments in the Department of Immunology and Department of Molecular Medicine. He holds the academic rank of Assistant Professor of Medicine, Oncology, and Immunology in Mayo Clinic College of Medicine. As a physician-scientist, he directs a federally funded translational laboratory program focused on T cell biology, cellular engineering, and chimeric antigen receptor T (CART) cell therapy. In this context, he collaborates with multiple pharmaceutical and biotech companies. Since 2019, three clinical trials have been translated from his laboratory, two of them are multi-center trials. He has authored more than 90 manuscripts and book chapters. He is an inventor on multiple patent applications and is the Principal Investigator on 5 active clinical trials.